Evoleen AG
Evoleen AG is a Zurich-based digital health venture builder founded in 2018 that co-creates, certifies, and scales AI-enabled medical devices and digital therapeutics with pharma, medtech, governments, and health startups, operating an ecosystem of 11 portfolio companies across Europe, the Middle East, Asia, and the USA.
- Company typePrivate
- Founded2018
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Evoleen AG does
Evoleen AG is a Zurich-based digital health venture builder founded in 2018 that designs, co-creates, certifies, and scales medical-grade digital health solutions and smart medical devices on behalf of pharmaceutical companies, medtech firms, governments, and healthcare startups. The company operates an end-to-end delivery model covering strategy, engineering, clinical validation, regulatory certification, and market deployment, and is structured around three interconnected pillars: the parent Evoleen (venture building), Evoleen Technology GmbH in Munich (engineering and AI/ML capabilities), and Evoleen Access (regulatory, quality, and clinical affairs).
The product portfolio spans certified platforms including SIVA (continuous AI-powered cough monitoring with >94% sensitivity), DigeHealth (acoustic-AI wearable for gastrointestinal monitoring), ProJo (clinical trial engagement chatbot delivering 97% data completeness), Collabree (hypertension digital therapeutic with +25% adherence uplift), Fire Arrow (EHR integration and AI workflow platform), and Carity (cardiac rehabilitation companion), alongside co-built projects such as K!M, WINGS, MachineMD neos, AssureYou, CITUS NIMBLE, Hospital@Home, and Hello Mirrors. Evoleen holds ISO 13485, MDR, FDA 21 CFR Part 11, HIPAA, and GDPR credentials, with regulatory coverage from Class I to Class III and active implantable devices.
Commercially, Evoleen charges professional services fees and milestone-based pricing with success-fee risk-sharing on multi-year engagements, and captures upside from wholly-owned portfolio ventures through licensing, royalties, and equity value. The company is geographically anchored in Switzerland with engineering operations in Munich and a regional hub in Riyadh (Evoleen KSA) tied to Saudi Arabia's Vision 2030 health sector transformation, and serves clients across Europe, the USA, Asia, and the Middle East. Disclosed financials are limited; only one portfolio-company funding event is on record (DigeHealth CHF 1.25M seed in 2023), and no parent-level revenue has been published.
Evoleen AG firmographics
Firmographics- Name
- Evoleen AG
- Legal name
- Evoleen AG
- Website
- https://evoleen.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Evoleen AG is a Zurich-based digital health venture builder founded in 2018 that co-creates, certifies, and scales AI-enabled medical devices and digital therapeutics with pharma, medtech, governments, and health startups, operating an ecosystem of 11 portfolio companies across Europe, the Middle East, Asia, and the USA.
- Ownership category
- akta.pro rank
Evoleen AG industry classification
Industry- Product category
- Digital Health Venture Building Services
- NAICS
- Software Publishers (5132), Computer Systems Design Services (541512), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Services-Computer Integrated Systems Design (7373), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where Evoleen AG is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Evoleen AG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Professional Services: Evoleen provides end-to-end services including strategy, engineering, clinical validation, certification, and market deployment. They charge attractive hourly rates and use a disruptive fee-for-service approach.
- Milestone-Based Pricing: Services structured around milestones with predefined success fees, aligning incentives for real impact and sharing risk with partners
- Venture Portfolio: Revenue from portfolio companies including DigeHealth, SIVA Health, Carity, Collabree, and other digital health ventures
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Fee-for-service with risk sharing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Evoleen AG product offering
Product offeringCore offering
Evoleen AG is a digital health venture builder that partners with pharma, medtech, governments, and healthcare institutions to ideate, develop, clinically validate, certify, and deploy digital health solutions and smart medical devices end-to-end. The company operates a portfolio of subsidiaries (Evoleen Technology, Evoleen Access, Evoleen KSA) and portfolio ventures (SIVA, DigeHealth, ProJo, Collabree, Carity, Fire Arrow) delivering AI/ML-powered products across cough monitoring, gastrointestinal diagnostics, clinical trial engagement, hypertension, and cardiac rehabilitation.
Product overview
Evoleen AG operates as a digital health venture builder offering a portfolio of distinct branded products and services for healthcare transformation. The core product portfolio includes SIVA (AI-powered medical-grade cough monitoring wearable), DigeHealth (gastrointestinal monitoring platform), ProJo (clinical trial engagement chatbot), Collabree (digital therapeutic for hypertension), Fire Arrow (backend/EHR integration platform), Carity (cardiac rehabilitation app), K!M (patient onboarding co-pilot), and WINGS (cancer patient support app). The company is organized into three interconnected ecosystem pillars: Evoleen (end-to-end venture building), Evoleen Technology (engineering and AI/ML services), and Evoleen Access (regulatory and market access services). Additional ventures include Hospital@Home, MachineMD, AssureYou, and CITUS, developed through partnerships and portfolio investments. The ecosystem comprises 25 pipeline projects, 11 portfolio companies, and collaborations with over 20 corporate partners in pharma and medtech.
Differentiator
Problem solved
Functional benefit
Brands
- ProJo: Clinical trial engagement chatbot and monitoring tool enabling seamless real-time data collection during clinical trials and medical practice, achieving 97% data completeness without manual intervention.
- Collabree
- SIVA
- DigeHealth
- Fire Arrow
- Evoleen Technology
- Evoleen Access
- Evoleen Ventures
Products and services
- SIVA Medical-grade wearable device for continuous AI-powered cough monitoring, providing objective cough profiling 24/7 with proprietary certified technology achieving >94% sensitivity and precision. Sold to pharma, medtech, and clinical research partners.
- DigeHealth Digital health platform for gastrointestinal monitoring, combining a wearable acoustic device with AI-powered data models to provide real-world gut health insights and treatment optimization for patients and clinical partners.
- ProJo Clinical trial engagement chatbot and monitoring tool enabling seamless real-time patient data collection during clinical trials and medical practice, achieving 97% data completeness without manual intervention. Designed for pharma sponsors and clinical research teams.
- Collabree Digital therapeutic application for hypertension management featuring a digital companion that motivates patients, rewards healthy habits, and drives sustainable behavioral change to improve adherence and outcomes. Certified adherence feature set delivering +25% adherence uplift.
- Fire Arrow Backend platform providing certified workflows, rapid deployment capabilities, EHR integration, and AI-powered workflow automation for healthcare organizations and digital health vendors.
- Carity Digital companion app for cardiac rehabilitation that prevents secondary cardiac events by enabling patients to build long-term personalized cardiac rehab programs after acute heart attacks. Used in clinical settings with multi-site study support.
- K!M Patient onboarding co-pilot that streamlines hospital patient education, consent processes, and hospital stay information with individualized workflows integrated into existing hospital information systems. Deployed at hospital sites.
- WINGS Mobile health application providing holistic cancer patient support through validated content, social-emotional support, and shared activities with friends and relatives to reduce isolation.
- Evoleen Technology Engineering and software development services subsidiary offering tech stack and AI/ML capabilities for healthcare solution development, supporting Evoleen's venture portfolio and external clients.
- Evoleen Access Regulatory, quality, and clinical affairs services subsidiary helping healthcare companies navigate market entry, MDR/IVDR compliance, ISO 13485 quality systems, and certification processes.
- End-to-End Venture Building End-to-end venture building service covering strategy, engineering, clinical validation, certification, and market deployment of digital health solutions and smart medical devices for pharma, medtech, and government clients.
Quantifiable outcome
- 100% patient engagement and €2,000 cost savings per patient with ProJo
- +3 more outcomes
Companies that use Evoleen AG
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
Evoleen AG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature6 records
Evoleen AG partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- Saudi Arabia Ministry of Health (Model of Care)coreCollaboration framework agreement signed during Global Health Exhibition 2025 in Riyadh to support Saudi Arabia's Vision 2030 and Health Sector Transformation Program. Evoleen contributes expertise and portfolio to transform healthcare and implement model of care in Saudi Arabia.
- Rothschild & CosupportingJoint investor-startup meetup event where Evoleen shared insights on treating chronic diseases and supporting healthy aging. More than 60 participants received unique insights through this partnership.
- MachineMDcoreStrategic partnership where Evoleen advances software development, web application, and cloud infrastructure for MachineMD's neos™ VR-based brain function assessment device. Evoleen manages cloud infrastructure to make patient data accessible to doctors globally, enabling better diagnostics and overcoming geographical barriers.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Evoleen AG competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global CRO and healthcare data company with technology platforms for clinical trials, real-world evidence, and commercial analytics. Overlaps with Evoleen's clinical trial work (ProJo) and broader pharma services, but at massive scale and across all therapeutic areas.
- Syneos Health: Fully integrated biopharmaceutical solutions organization offering clinical development and commercial services. Comparable to Evoleen for end-to-end pharma services and clinical trial capabilities, though at far greater scale and breadth.
- Biofourmis: Digital therapeutics and remote patient monitoring company using AI and wearable biosensors for chronic disease management. Comparable to Evoleen's SIVA wearable monitoring and Collabree digital therapeutic offerings in cardiology and chronic care.
- ZS Associates: Global management consulting and technology firm with a large healthcare practice serving pharma and medtech on strategy, analytics, and digital transformation. Comparable to Evoleen's pharma/medtech advisory and solution-building work for enterprise clients.
Direct peers
- Roivant Sciences: Healthcare-focused venture builder that creates, acquires, and operates multiple subsidiary biopharma and digital health companies with shared infrastructure. Closely comparable to Evoleen's portfolio model of building multiple specialized health ventures under a parent umbrella.
- Medable: Decentralized clinical trial platform offering eCOA/ePRO, telehealth, and patient engagement tools for pharma and CROs. Directly comparable to Evoleen's ProJo clinical trial engagement platform and similar target customers in pharma and CROs.
- Science 37: Decentralized clinical trial operator enabling remote participation with telemedicine, eConsent, and connected devices. Comparable to Evoleen's clinical trial technology capabilities (ProJo, Fire Arrow) and shared pharma/biotech customer base.
- Castor: Cloud-based clinical trial data platform offering EDC, ePRO, and eConsent for researchers and sponsors. Directly competes with Evoleen's ProJo for clinical trial data capture and monitoring workflows in pharma and academic settings.
Emerging players
- Curebase: Decentralized clinical trial software platform enabling hybrid and fully remote trials. Comparable to ProJo's clinical trial engagement capabilities with similar pharma and biotech customers.
- ObvioHealth: Digital clinical trial platform focused on decentralized and hybrid trials for sponsors. Comparable to Evoleen's clinical trial engagement work but with a narrower product focus on DCT operations rather than a full venture-building model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Evoleen AG social profiles
Digital presenceEvoleen AG compliance and trust
Trust signalCompliance5 records
Evoleen AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evoleen AG leadership team
Management profileNumber of profiles
Profiles10 records
Evoleen AG subsidiaries and ownership
Company hierarchySubsidiaries7 records
Evoleen AG funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evoleen AG M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evoleen AG
What does Evoleen AG do?
Evoleen AG is a digital health venture builder that partners with pharma, medtech, governments, and healthcare institutions to ideate, develop, clinically validate, certify, and deploy digital health solutions and smart medical devices end-to-end. The company operates a portfolio of subsidiaries (Evoleen Technology, Evoleen Access, Evoleen KSA) and portfolio ventures (SIVA, DigeHealth, ProJo, Collabree, Carity, Fire Arrow) delivering AI/ML-powered products across cough monitoring, gastrointestinal diagnostics, clinical trial engagement, hypertension, and cardiac rehabilitation.
Is Evoleen AG a public or private company?
Evoleen AG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Evoleen AG founded?
Evoleen AG was founded in 2018. It employs 11 to 50 people.
Where is Evoleen AG based?
Evoleen AG is headquartered in Zürich, Switzerland, in the Europe region.
How does Evoleen AG make money?
Three revenue lines are on record. Professional Services are the primary driver. The others are milestone-Based Pricing and venture Portfolio.
Who are Evoleen AG's main competitors?
Broad incumbents on record are IQVIA, Syneos Health, Biofourmis and ZS Associates. Direct peers are Roivant Sciences, Medable, Science 37 and Castor. Emerging players are Curebase and ObvioHealth.
Does Evoleen AG have an API?
No public API is recorded for Evoleen AG.
What industry is Evoleen AG in?
Evoleen AG's product category is Digital Health Venture Building Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 5132 and its SIC code is 7373.